ARTICLE | Company News
AstraZeneca, Shionogi endocrine/metabolic news
July 25, 2016 7:00 AM UTC
The U.S. District Court for the District of Columbia denied a motion from AstraZeneca seeking a temporary restraining order to prevent FDA from approving generic versions of Crestor rosuvastatin. Aft...